We are pleased to announce the release of an updated version of the Simulacrum containing two additional years of diagnostic data (2013 – 2017 diagnoses) and treatment follow up to March 2018.
This new version of the Simulacrum contains almost twice as many synthetic patients as the previous version and over 900,000 new tumours. The vital status of each synthetic patient is now simulated up to February 2019.
The data dictionary for this release (version 1.2017) is the same as the previous release. To download the new version, please visit the Simulacrum website.
Release comparison chart
|Simulacrum v1.1.0 (2015)||Simulacrum v1.2.0 (2017)|
|Stages 0 – 4 (including non-melanoma skin cancers)||821,454||1,402,070|
|Stages 1 – 4||659,948||1,137,676|
|Synthetic patients with SACT data||245,938||366,266|
|SACT drug administrations||3,533,584||6,385,828|
|Non-melanoma skin cancers (C44)||350,130||607,619|
|Breast cancer (C50)||133,907||226,406|
|Prostate cancer (C61)||119,347||201,785|
|Lung cancer (C34)||102,350||169,118|